Skip to main content
Novo Nordisk A/S (NVO)
NYSE: NVO · Real-Time Price · USD
41.17
-0.03 (-0.07%)
At close: Apr 28, 2026, 4:00 PM EDT
41.18
+0.01 (0.02%)
After-hours: Apr 28, 2026, 5:44 PM EDT

Novo Nordisk Revenue by Segment
Period Ending Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019
Diabetes
33.74B 33.54B 33.33B 32.52B 31.18B 30.34B 28.72B 27.30B
Diabetes Growth
8.19% 10.57% 16.05% 19.11% 22.93% 24.59% 23.92% 24.31%
Obesity
12.80B 12.43B 11.42B 10.25B 8.65B 7.62B 7.06B 6.55B
Obesity Growth
47.92% 63.15% 61.82% 56.48% 53.16% 73.14% 110.41% 146.87%
Rare Disease
3.14B 3.12B 2.97B 2.93B 2.76B 2.65B 2.67B 2.70B
Rare Disease Growth
14.05% 17.73% 11.21% 8.60% 0.34% -9.75% -14.09% -16.45%

Operating Income by Segment
Period Ending Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019
Diabetes and Obesity Care
20.69B 22.14B 21.21B 20.10B 18.53B 17.46B 16.79B 15.68B
Diabetes and Obesity Care Growth
11.67% 26.80% 26.31% 28.20% 29.95% 35.29% 41.90% 47.82%
Rare Disease
191.24M 331.16M 84.36M 97.59M 104.04M 79.33M 430.48M 464.48M
Rare Disease Growth
83.81% 317.46% -80.40% -78.99% -71.50% -87.86% -50.18% -60.20%

Revenue by Geography
Period Ending Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019Sep 30, 2019Jun 30, 2019Mar 31, 2019Dec 31, 2018
North America
28.93B 29.16B 28.84B 28.04B 26.04B 24.85B 23.08B 21.50B
North America Growth
11.10% 17.33% 24.96% 30.41% 37.09% 44.35% 46.01% 49.97%
International
20.75B 19.94B 18.88B 17.66B 16.55B 15.76B 15.37B 15.05B
International Growth
25.36% 26.54% 22.84% 17.36% 12.08% 8.89% 11.10% 11.40%
Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.